Cargando…
Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign
BACKGROUND: Historically, Neisseria meningitidis serogroup A (NmA) caused large meningitis epidemics in sub-Saharan Africa. In 2010, Burkina Faso became the first country to implement a national meningococcal serogroup A conjugate vaccine (MACV) campaign. We analyzed nationwide meningitis surveillan...
Autores principales: | Diallo, Alpha Oumar, Soeters, Heidi M., Yameogo, Issaka, Sawadogo, Guetawendé, Aké, Flavien, Lingani, Clément, Wang, Xin, Bita, Andre, Fall, Amadou, Sangaré, Lassana, Ouédraogo-Traoré, Rasmata, Medah, Isaïe, Bicaba, Brice, Novak, Ryan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667755/ https://www.ncbi.nlm.nih.gov/pubmed/29095907 http://dx.doi.org/10.1371/journal.pone.0187466 |
Ejemplares similares
-
Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso
por: Ba, Absatou Ky, et al.
Publicado: (2014) -
Initial validation of a simulation model for estimating the impact of serogroup A Neisseria meningitidis vaccination in the African meningitis belt
por: Jackson, Michael L., et al.
Publicado: (2018) -
Persistent low carriage of serogroup A Neisseria meningitidistwo years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac
por: Kristiansen, Paul A, et al.
Publicado: (2014) -
MenAfriVac as an Antitetanus Vaccine
por: Borrow, Ray, et al.
Publicado: (2015) -
Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac
por: Tang, Yuxiao, et al.
Publicado: (2015)